• Home
  • NAMs & SVC
  • Cell Customization

Cell Customization

Patient-Derived iPSC Differentiation Service

Differentiation Efficiency Analysis of Patient-Derived iPSC-Cardiomyocytes

We offer a CDMO services to differentiate iPSCs into various cell types, such as cardiomyocytes, neurons, and hepatocytes, and analyze their differentiation efficiency through gene expression (RT-PCR), morphology, FACS, and ICC analysis.

The service includes

  • Differentiation of iPSCs into target cell types
  • Evaluation of differentiation efficiency using various analytical methods
  • Delivery of 3 vials (> 1x10^6 cells/vial) of the differentiated cells
  • Comprehensive result analysis report

The estimated duration of the service is approximately 1 to 3 months, depending on the stabilization process.

Beyond conventional boundaries,
we deliver a bold new paradigm.

  • iPSC technologyCONTACT

    Contact Information

    • Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)

    • Business Registration No.: 109-86-37282
    • CEO: Choongseong Han

    • Tel : +82-2-2088-8886
    • Fax: +82-2-2088-8884
    • E-mail : support@nexel.co.kr